Here, we show that blockade of PD‐L1 strongly enhanced tumor response to high (12, 5 × 3, and 20 Gy) but not low (6 and 5 × 2 Gy) RT doses, albeit a trend was noted for low doses. The gene discussed is CD274; the disease is neoplasm.